https://www.selleckchem.com/pr....oducts/vazegepant-hy
The above results were confirmed after performing PSM analysis at a 12 and 13 ratio. Conclusion By applying several effective sensitivity analyses, we demonstrated that OS and CSS were similar between the patients with tumors smaller than 3 cm receiving RFA and SR. But SR may be a superior treatment option with better long-term outcome than RFA in patients with tumor measuring 3.1-5 cm. Copyright © 2020 Zheng, Zhang, Lin, Song, Qi and Luo.Acute myeloid leukemia is a heterogeneous disease with a 5-year survival rate of 2
Like
Comment
Share
